FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2009166532> ?p ?o ?g. }

• W2009166532 endingPage "770" @default.
• W2009166532 startingPage "763" @default.
• W2009166532 abstract "1. Antagonistic properties of OPC-28326 ([4-(N-methyl-2-phenylethylamino)-1-(3,5-dimethyl-4-propionyl-aminobenzoyl)] piperidine hydrochloride monohydrate), a selective peripheral vasodilator, were investigated by analysing the data from functional studies in various tissues from the rat and binding studies of the drug to alpha(2)-adrenoceptor subtypes. 2. Using a human recombinant receptor and rat kidney cortex, we found that OPC-28326 displays affinities to alpha(2A)-, alpha(2B)- and alpha(2C)-adrenoceptors with K(i) values of 2040, 285, and 55 nM, respectively. The K(i) values of yohimbine for alpha(2A)-, alpha(2B)-, and alpha(2C)-adrenoceptors were 3.0, 2.0 and 11.0 nM, respectively. 3. B-HT 920, an alpha(2)-adrenoceptor agonist, produced a pressor response via peripheral postsynaptic alpha(2)-adrenoceptor stimulation (thought to be an alpha(2B)-subtype) in a reserpine-pretreated pithed rat preparation. OPC-28326 (3 - 30 mg kg(-1), i.v.) and yohimbine (0.3 - 3 mg kg(-1), i.v.) caused dose-dependent rightward shift in the pressor dose-response curve induced by B-HT 920. The apparent pA(2) values were 1.55 (0.87 - 2.75, 95% confidence interval) and 0.11 (0.06 - 0.21) mg kg(-1), respectively. The potency of OPC-28326 was about 14 times less than that of yohimbine. 4. Clonidine inhibited the tension developed by electrical stimulation, of the rat vas deferens, by its peripheral presynaptic alpha(2A/D)-adrenoceptor action. OPC-28326 (1 - 100 microM) and yohimbine (10 - 1000 nM) caused a rightward shift in the concentration-response curve of clonidine. The pA(2) values were 5.73 (5.54 - 5.91) and 7.92 (7.84 - 8.01), respectively, providing evidence for a potency of OPC-28326 of about 155 times less than that of yohimbine. 5. Mydriasis was induced by brimonidine via stimulation of central alpha(2A/D)-adrenoceptors in anaesthetized rats. Intravenous OPC-28326 had no effect on this action, even at a very high dose of 10 mg kg(-1) i.v., while yohimbine (0.1 - 0.3 mg kg(-1) i.v.) inhibited mydriasis in a dose-dependent manner, indicating that OPC-28326 was at least 100 times less potent than yohimbine in regard to the anti-mydriatic effect. 6. These data suggest that OPC-28326 preferentially exerts peripheral and postsynaptic antagonistic actions on the alpha(2B)- and alpha(2C)-adrenoceptor subtypes." @default.
• W2009166532 created "2016-06-24" @default.
• W2009166532 creator A5000962006 @default.
• W2009166532 creator A5022621431 @default.
• W2009166532 creator A5050204817 @default.
• W2009166532 creator A5070259288 @default.
• W2009166532 creator A5077862856 @default.
• W2009166532 creator A5081133146 @default.
• W2009166532 creator A5082234778 @default.
• W2009166532 date "2001-10-01" @default.
• W2009166532 modified "2023-10-18" @default.
• W2009166532 title "α₂-adrenoceptor antagonist properties of OPC-28326, a novel selective peripheral vasodilator" @default.
• W2009166532 cites W1592358009 @default.
• W2009166532 cites W1968082942 @default.
• W2009166532 cites W1980118118 @default.
• W2009166532 cites W1988256011 @default.
• W2009166532 cites W1998320010 @default.
• W2009166532 cites W2009182409 @default.
• W2009166532 cites W2018452659 @default.
• W2009166532 cites W2027951993 @default.
• W2009166532 cites W2031481729 @default.
• W2009166532 cites W2042535040 @default.
• W2009166532 cites W204404340 @default.
• W2009166532 cites W2057971042 @default.
• W2009166532 cites W2074631079 @default.
• W2009166532 cites W2077733164 @default.
• W2009166532 cites W2080202671 @default.
• W2009166532 cites W2080875624 @default.
• W2009166532 cites W2084235775 @default.
• W2009166532 cites W2089442650 @default.
• W2009166532 cites W2135533851 @default.
• W2009166532 cites W2152134973 @default.
• W2009166532 cites W2156960407 @default.
• W2009166532 cites W2173726217 @default.
• W2009166532 cites W2260443568 @default.
• W2009166532 cites W2277288131 @default.
• W2009166532 cites W2278217549 @default.
• W2009166532 cites W2283395189 @default.
• W2009166532 cites W2417613139 @default.
• W2009166532 cites W3325316 @default.
• W2009166532 cites W4244721650 @default.
• W2009166532 doi "https://doi.org/10.1038/sj.bjp.0704309" @default.
• W2009166532 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1573002" @default.
• W2009166532 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11606316" @default.
• W2009166532 hasPublicationYear "2001" @default.
• W2009166532 type Work @default.
• W2009166532 sameAs 2009166532 @default.
• W2009166532 citedByCount "9" @default.
• W2009166532 countsByYear W20091665322014 @default.
• W2009166532 countsByYear W20091665322021 @default.
• W2009166532 countsByYear W20091665322023 @default.
• W2009166532 crossrefType "journal-article" @default.
• W2009166532 hasAuthorship W2009166532A5000962006 @default.
• W2009166532 hasAuthorship W2009166532A5022621431 @default.
• W2009166532 hasAuthorship W2009166532A5050204817 @default.
• W2009166532 hasAuthorship W2009166532A5070259288 @default.
• W2009166532 hasAuthorship W2009166532A5077862856 @default.
• W2009166532 hasAuthorship W2009166532A5081133146 @default.
• W2009166532 hasAuthorship W2009166532A5082234778 @default.
• W2009166532 hasBestOaLocation W20091665322 @default.
• W2009166532 hasConcept C126322002 @default.
• W2009166532 hasConcept C134018914 @default.
• W2009166532 hasConcept C159110408 @default.
• W2009166532 hasConcept C170493617 @default.
• W2009166532 hasConcept C185592680 @default.
• W2009166532 hasConcept C24998067 @default.
• W2009166532 hasConcept C2775944032 @default.
• W2009166532 hasConcept C2776504411 @default.
• W2009166532 hasConcept C2776885963 @default.
• W2009166532 hasConcept C2777676773 @default.
• W2009166532 hasConcept C2777842393 @default.
• W2009166532 hasConcept C2778210472 @default.
• W2009166532 hasConcept C2778399450 @default.
• W2009166532 hasConcept C2778938600 @default.
• W2009166532 hasConcept C2780648677 @default.
• W2009166532 hasConcept C49453240 @default.
• W2009166532 hasConcept C64943373 @default.
• W2009166532 hasConcept C71924100 @default.
• W2009166532 hasConcept C98274493 @default.
• W2009166532 hasConceptScore W2009166532C126322002 @default.
• W2009166532 hasConceptScore W2009166532C134018914 @default.
• W2009166532 hasConceptScore W2009166532C159110408 @default.
• W2009166532 hasConceptScore W2009166532C170493617 @default.
• W2009166532 hasConceptScore W2009166532C185592680 @default.
• W2009166532 hasConceptScore W2009166532C24998067 @default.
• W2009166532 hasConceptScore W2009166532C2775944032 @default.
• W2009166532 hasConceptScore W2009166532C2776504411 @default.
• W2009166532 hasConceptScore W2009166532C2776885963 @default.
• W2009166532 hasConceptScore W2009166532C2777676773 @default.
• W2009166532 hasConceptScore W2009166532C2777842393 @default.
• W2009166532 hasConceptScore W2009166532C2778210472 @default.
• W2009166532 hasConceptScore W2009166532C2778399450 @default.
• W2009166532 hasConceptScore W2009166532C2778938600 @default.
• W2009166532 hasConceptScore W2009166532C2780648677 @default.
• W2009166532 hasConceptScore W2009166532C49453240 @default.
• W2009166532 hasConceptScore W2009166532C64943373 @default.
• W2009166532 hasConceptScore W2009166532C71924100 @default.
• W2009166532 hasConceptScore W2009166532C98274493 @default.

• next